NCT06318104View on ClinicalTrials.gov

Efficacy and Safety of a Triple Eradication Scheme for Helicobacter Pylori Based on Tegoprazan vs Esomeprazole

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

April 19, 2024

Primary Completion Date

November 29, 2024

Study Completion Date

February 28, 2025

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Tegoprazan

Tegoprazan 50 mg BID + amoxicillin 1 gr BID + clarithromycin 500 mg BID all for 14 days.

DRUG

Esomeprazole 40mg

Esomeprazole 40 mg BID + amoxicillin 1 gr BID + clarithromycin 500 mg BID all for 14 days.

All Listed Sponsors
lead

Hospital General de México Dr. Eduardo Liceaga

OTHER_GOV

NCT06318104 - Efficacy and Safety of a Triple Eradication Scheme for Helicobacter Pylori Based on Tegoprazan vs Esomeprazole | Biotech Hunter | Biotech Hunter